Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Peter F J Ryan"'
Publikováno v:
Rheumatology. 44:1122-1131
OBJECTIVES The aim of this study was to describe expression of parathyroid hormone-related peptide (PTHrP) in collagen-induced arthritis (CIA), a well-established animal model for rheumatoid arthritis. METHODS CIA was induced in female dark agouti ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee730163973000f607ae1ed6c42b46d8
https://doi.org/10.1093/rheumatology/keh690
https://doi.org/10.1093/rheumatology/keh690
Publikováno v:
Rheumatology. 52:2302-2304
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ce63f0e92e6cba3644a8874b6341bf41
https://doi.org/10.1093/rheumatology/ket175
https://doi.org/10.1093/rheumatology/ket175
Autor:
Daphne K. Hards, T. John Martin, Matthew T. Gillespie, Natalie A. Sims, Julian M.W. Quinn, Peter F J Ryan, Mandy Lee Lindsay, Colin R. Dunstan, E. Romas
Publikováno v:
The American Journal of Pathology. 161:1419-1427
Rheumatoid arthritis is characterized by progressive synovial inflammation and joint destruction. While matrix metalloproteinases (MMPs) are implicated in the erosion of unmineralized cartilage, bone destruction involves osteoclasts, the specialized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3892e5bc45610cb787b0d59080c6cab
https://doi.org/10.1016/s0002-9440(10)64417-3
https://doi.org/10.1016/s0002-9440(10)64417-3
Autor:
Anita E. Wluka, Peter Bergin, Peter F J Ryan, Ashley M Miller, Judith L Page, Donald S. Esmore, Meroula Richardson
Publikováno v:
The Journal of Heart and Lung Transplantation. 19:951-956
Objective To study the clinical impact of gout treatment following cardiac transplantation. Methods We performed an audit of all cardiac transplant recipients of the Alfred Hospital before August 1998 who lived in Victoria. Results We studied 225 pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54ffd350d7965fe2843d58b4255a0bb8
https://doi.org/10.1016/s1053-2498(00)00175-3
https://doi.org/10.1016/s1053-2498(00)00175-3
Autor:
Indi Rasaratnam, Peter F J Ryan
Publikováno v:
Medical Journal of Australia. 166:322-327
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a00f1d4d76a78f91cfff39a8def9cfe
https://doi.org/10.5694/j.1326-5377.1997.tb122325.x
https://doi.org/10.5694/j.1326-5377.1997.tb122325.x
Autor:
Peter F J Ryan, Indi Rasaratnam
Publikováno v:
Medical Journal of Australia. 166:266-270
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dffac1df52e712b414d64e0c52086705
https://doi.org/10.5694/j.1326-5377.1997.tb140110.x
https://doi.org/10.5694/j.1326-5377.1997.tb140110.x
Autor:
I D Steven, Lawrence J. Beilin, Trefor Morgan, John Shaw, Mark Brown, Lindon M H Wing, Garry L. Jennings, Peter F J Ryan, Malcolm J. West, John Marley, Christopher M. Reid, John J McNeil, Colin I. Johnston
Publikováno v:
Clinical and Experimental Pharmacology and Physiology. 24:188-192
1, ANBP2 is a comparative outcome trial of angiotensin-converting enzyme inhibitor- and diuretic-based treatment of hypertension in the elderly using a prospective randomized open-label design with blinding of endpoint assessments
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cceb5b9a0e288a71707f562ee171fa5f
https://doi.org/10.1111/j.1440-1681.1997.tb01806.x
https://doi.org/10.1111/j.1440-1681.1997.tb01806.x
Publikováno v:
Journal of alternative and complementary medicine (New York, N.Y.). 18(11)
Chinese medicine (CM) has its own diagnostic indicators that are used as evidence of change in a patient's condition. The majority of studies investigating efficacy of Chinese herbal medicine (CHM) have utilized biomedical diagnostic endpoints. For C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ba16e28a4be0c01c5443d67ae2cba03
https://pubmed.ncbi.nlm.nih.gov/22897413
https://pubmed.ncbi.nlm.nih.gov/22897413
Autor:
Peter F J Ryan, R. H. Mullan
Publikováno v:
Rheumatology. 41:1200-1202
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::81df58eca967c991b94559a54c33891d
https://doi.org/10.1093/rheumatology/41.10.1200
https://doi.org/10.1093/rheumatology/41.10.1200
Autor:
I. M. Biagini, F. Van den Bosch, S. A. Roberson, J. Sloan-Lancaster, Mark C. Genovese, Peter F J Ryan, S. Bojin
Publikováno v:
Arthritis and rheumatism. 62(4)
Objective We undertook this study to evaluate safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of LY2439821, a humanized anti–interleukin-17 (anti–IL-17) monoclonal antibody, in a first in-human trial in rheumatoid arthritis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::002407ce66adb73864db12d27cd32152
https://pubmed.ncbi.nlm.nih.gov/20131262
https://pubmed.ncbi.nlm.nih.gov/20131262